Frontier IP Group

Exscientia - Statement filed for proposed IPO

RNS Number : 4883L
Frontier IP Group plc
13 September 2021
 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

RNS

AIM: FIPP

13 September 2021

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Registration statement filed for proposed initial public offering of Exscientia in the United States

 

Frontier IP, a specialist in commercialising intellectual property, notes a registration statement on Form F-1 (the "Registration Statement") has been filed for portfolio company Exscientia Limited with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed initial public offering of Exscientia (the "IPO") in the United States of its Share Securities ("Share Securities").

 

The Registration Statement relating to the Share Securities has been filed with the SEC but has not yet become effective. The Registration Statement can be accessed at the following link: https://www.sec.gov/Archives/edgar/data/1865408/000110465921114491/tm2119783-5_f1.htm

 

At this stage there can be no certainty on the IPO proceeding nor the terms or timing of the IPO.

 

Further announcements will be made by Frontier IP at the appropriate time.

 

 

ENQUIRIES

 

 

Frontier IP Group Plc

T: 020 3968 7815

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

[email protected]

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

Singer Capital Markets (Broker)

Sandy Fraser / Harry Gooden / George Tzimas

 

T: 0203 328 5656

 

 

T: 0207 496 3000

 

 

 

 

ABOUT FRONTIER IP

 

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

 

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUSFFEDEEFSEEU